Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Crown BioScience
Crown BioScience
Activities:
Research & Development
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Graphs and graph data science in drug discovery
Life sciences data expert Dr Alexander Jarasch discusses what work being done at the Institut de Recherches Servier can teach us about using modern data technologies for early...
Why smaller CDMOs should enhance their operational efficiency now: a CPHI expert guide
CPHI experts advise smaller CDMO's to invest in supply chain resilience, friend shoring and AI to keep up with the predicted uptick in funding for 2025
CPI collaborates with industry leaders to expedite drug manufacturing via digitisation
Digitising manufacturing technologies could allow enhanced ability to scale production, reduce costs and expedite the process
Janssen to adopt Johnson & Johnson brand as the company celebrates 100 years of UK operation
The company's pharmaceutical and medical technology segments will combine under the Johnson & Johnson brand name in the UK
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Finance
JSR Life Sciences companies form Japanese joint venture
Based in Tokyo, the venture will establish a local team led by an experienced General Manager, Hiroki Itou
Research & Development
Crown Bioscience opens oncology biomarker R&D centre in California
New custom-designed 32,000 sqft facility in San Diego to support the growth of both oncology biomarker and inflammation service portfolios
Research & Development
Crown Bioscience and Charles River agree to expand access to ZDSD rat model
The agreement enables greater global model availability for drug discovery in obesity, diabetes and metabolic syndrome
Research & Development
Crown Bioscience creates Center of Excellence for bioinformatics, big data and biomarker discovery
Services and capacity increase with new site opening
Research & Development
Crown Bioscience expands cardiovascular and metabolic disease research capability
The company offers new non-GLP services and translational rodent models at its expanded site in Louisiana
Research & Development
CrownBio expands humanised models for targeted immunotherapy
The humanised model expansion programme will begin with PD-1, CTLA-4 and CD137 models
Research & Development
Grant awarded to doctors researching innovative PDX models in immuno-oncology
Crown Bioscience awarded Dr Lavial and his colleagues the grant due to their project's potential to create breakthroughs in preclinical oncology strategies
Subscribe now